Prosecution Insights
Last updated: May 29, 2026

VASCULAR MEDCURE, INC.

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
4
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (75%)
0
Easy (0%)
1
Unknown (25%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
§102 only1 (25%)
No statute on record1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RWEGO, KANKINDI 1 74.5% +35.1%
POLAND, CHERIE MICHELLE 1 58.8% +33.8%
STRANSKY, KATRINA MARIE 1 74.2% +24.6%
NEMER, OSAMA MOHAMMAD 1 64.9% +53.8%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18661178 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM STRANSKY, KATRINA MARIE 9d
18909143 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM POLAND, CHERIE MICHELLE 13d
18551700 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM, TENSIONING SYSTEM AND EXPANDABLE FUNNEL CATHETER NEMER, OSAMA MOHAMMAD 41d
18940398 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM, TENSIONING SYSTEM AND EXPANDABLE FUNNEL CATHETER RWEGO, KANKINDI 42d

Top Art Units

Art UnitApps
3771 3
3700 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18940398 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM, TENSIONING SYSTEM AND EXPANDABLE FUNNEL CATHETER RWEGO, KANKINDI 3771 §103 Non-Final OA 42d Pending Nov 07, 2024
18909143 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM POLAND, CHERIE MICHELLE 3771 Other Non-Final OA 13d Pending Oct 08, 2024
18661178 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM STRANSKY, KATRINA MARIE 3700 §102 Non-Final OA 9d Pending May 10, 2024
18551700 AXIAL LENGTHENING THROMBUS CAPTURE SYSTEM, TENSIONING SYSTEM AND EXPANDABLE FUNNEL CATHETER NEMER, OSAMA MOHAMMAD 3771 §103 Non-Final OA 41d Pending Sep 21, 2023

Managing VASCULAR MEDCURE, INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month